A new cytometry service for customers interested in adding an antibody to track a specific cell type, pathway, or target on CLIA-validated 41-marker CyTOF panels

The StandardPlus service lets customers add an additional antibody to Teiko’s Standard 41-marker peripheral blood mononuclear cell (PBMC) or whole blood (WB) mass cytometry (CyTOF) panel to detect a specific marker of interest. Customers will receive a marker verification report, sample and gating quality control (QC) reports for each cohort of processed samples, and Base, Core, or Premier analysis and deliverables accessible through Teiko’s web application.

Customers appreciate our Standard CyTOF panels for their comprehensive coverage (800+ immune cell types and subsets), reproducibility (CLIA-validation), and flexible pricing (tiered options). However, drug developers often need to track a specific cell type, target, pathway, or a general marker of interest in their clinical trials that isn’t included in the Standard Panel. And while adding just one additional marker to a panel may sound trivial, it actually can take months of work and considerable ($30,000+) fees.

Now, with Teiko, it’s simple. You pick an antibody, and we verify that antibody on a CLIA-validated backbone. And we deliver in the order of weeks (not months) to verify and create a 42-marker CyTOF panel. Get in touch with us about your specific antibody, and we’ll give you a precise estimate.

Our new StandardPlus service ranges from only $100-$300 more per sample compared to our Standard mass cytometry panel. Reach out to us today for more details about how to customize your panel.